| A class of improved hybrid Hochberg–Hommel type step-up multiple test procedures J Gou, AC Tamhane, D Xi, D Rom Biometrika 101 (4), 899-911, 2014 | 51 | 2014 |
| Public face and private thrift in C hinese consumer behaviour L Lin, D Xi, RM Lueptow International journal of consumer studies 37 (5), 538-545, 2013 | 51 | 2013 |
| Clinical trials impacted by the COVID-19 pandemic: adaptive designs to the rescue? CU Kunz, S Jörgens, F Bretz, N Stallard, K Van Lancker, D Xi, S Zohar, ... Statistics in Biopharmaceutical Research 12 (4), 461-477, 2020 | 49 | 2020 |
| Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials M Akacha, J Branson, F Bretz, B Dharan, P Gallo, I Gathmann, ... Statistics in Biopharmaceutical Research 12 (4), 419-426, 2020 | 44 | 2020 |
| Allocating recycled significance levels in group sequential procedures for multiple endpoints D Xi, AC Tamhane Biometrical Journal 57 (1), 90-107, 2015 | 35 | 2015 |
| Hierarchical testing of a primary and a secondary endpoint in a group sequential design with different information times J Gou, D Xi Statistics in Biopharmaceutical Research, 2019 | 19 | 2019 |
| A unified framework for weighted parametric multiple test procedures D Xi, E Glimm, W Maurer, F Bretz Biometrical Journal 59 (5), 918-931, 2017 | 18 | 2017 |
| A general multistage procedure for k‐out‐of‐n gatekeeping D Xi, AC Tamhane Statistics in Medicine 33 (8), 1321-1335, 2014 | 16 | 2014 |
| Optimal exact tests for multiple binary endpoints R Ristl, D Xi, E Glimm, M Posch Computational Statistics & Data Analysis 122, 1-17, 2018 | 15 | 2018 |
| Seamless phase IIa/IIb and enhanced dose-finding adaptive design J Yuan, H Pang, T Tong, D Xi, W Guo, P Mesenbrink Journal of biopharmaceutical statistics 26 (5), 912-923, 2016 | 15 | 2016 |
| On the optimal timing of futility interim analyses D Xi, P Gallo, D Ohlssen Statistics in Biopharmaceutical Research 9 (3), 293-301, 2017 | 11 | 2017 |
| Replicability, reproducibility, and multiplicity in drug development F Bretz, W Maurer, D Xi Chance 32 (4), 4-11, 2019 | 10 | 2019 |
| Symmetric graphs for equally weighted tests, with application to the Hochberg procedure D Xi, F Bretz Statistics in Medicine 38 (27), 5268-5282, 2019 | 5 | 2019 |
| An additive boundary for group sequential designs with connection to conditional error D Xi, P Gallo Statistics in Medicine 38 (23), 4656-4669, 2019 | 5 | 2019 |
| “Step-Down Parametric Procedures for Testing Correlated Endpoints in a Group-Sequential Trial” by Yiyong Fu M Wolbers, E Glimm, D Xi Statistics in Biopharmaceutical Research 11 (1), 104-105, 2019 | 4 | 2019 |
| Multiplicity D Xi, E Glimm, F Bretz Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, 2016 | 4 | 2016 |
| Group sequential Holm and Hochberg procedures AC Tamhane, D Xi, J Gou Statistics in Medicine 40 (24), 5333-5350, 2021 | 3 | 2021 |
| Discussion on'Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials'. D Xi, F Bretz Biometrical journal. Biometrische Zeitschrift 64 (2), 243-245, 2021 | 3 | 2021 |
| Causal discoveries for high dimensional mixed data Z Cai, D Xi, X Zhu, R Li Statistics in Medicine 41 (24), 4924-4940, 2022 | 2 | 2022 |
| Graphical approaches for multiple comparison procedures D Xi, F Bretz Handbook of multiple comparisons, 91-119, 2021 | 2 | 2021 |
